Not Yet RecruitingPhase 2/3

Calcium Administration in Life-saving Management During Massive Hemorrhage

81 participantsStarted 2025-05-01

Plain-language summary

This study evaluates the feasibility of conducting a larger study on the impact of treating massive hemorrhage with calcium in trauma patients. Patients undergoing the Massive Hemorrhage Protocol (MHP) will be randomly assigned to receive either calcium gluconate or placebo drug after every 4 packs of units of RBCs received during the MHP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult trauma patients undergoing the MHP at Victoria Hospital, London, Ontario Exclusion Criteria: * Under the age of 18 * Pregnant

What they're measuring

Feasibility

Timeframe: Through study completion, an estimate of 1 year

Trial details

NCT IDNCT06820645

SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-30

Contact for this trial

Ian Ball, MD

519-685-8500 Ian.Ball@lhsc.on.ca

View on ClinicalTrials.gov More Massive Hemorrhage trials